Teiko Sumiyoshi

Membrane-Proximal Epitope Facilitates Efficient T Cell Synapse Formation by Anti-FcRH5/CD3 and Is a Requirement for Myeloma Cell Killing

Ji Li, Nicola J. Stagg, Jennifer Johnston et al. · Cancer Cell · 2017 · 292 citations · Full text

Life Sciences, Immunology, Oncology +17

A transcriptional MAPK Pathway Activity Score (MPAS) is a clinically relevant biomarker in multiple cancer types

Marie-Claire Wagle, Daniel C. Kirouac, Christiaan Klijn et al. · npj Precision Oncology · 2018 · 213 citations · Full text

Medicine, Cancer Biology, Oncology +17

Cevostamab Monotherapy Continues to Show Clinically Meaningful Activity and Manageable Safety in Patients with Heavily Pre-Treated Relapsed/Refractory Multiple Myeloma (RRMM): Updated Results from an Ongoing Phase I Study

Suzanne Trudel, Adam D. Cohen, Amrita Krishnan et al. · Blood · 2021 · 161 citations

Medicine, Pharmacology, Pharmacotherapy +9

CpeR is an activator required for expression of the phycoerythrin operon (<i>cpeBA</i>) in the cyanobacterium <i>Fremyella diplosiphon</i> and is encoded in the phycoerythrin linker‐polypeptide operon (<i>cpeCDESTR</i>)

John Cobley, A. Clay Clark, Siromi Weerasurya et al. · Molecular Microbiology · 2002 · 89 citations · Full text

Life Sciences, Genetics, Microbiology +12

Initial Clinical Activity and Safety of BFCR4350A, a FcRH5/CD3 T-Cell-Engaging Bispecific Antibody, in Relapsed/Refractory Multiple Myeloma

Adam D. Cohen, Simon J. Harrison, Amrita Krishnan et al. · Blood · 2020 · 76 citations

Life Sciences, Hematology, Immunology +16